The U.S. Patent and Trademark Office will be holding its next biotechnology/chemical/pharmaceutical (BCP) customer partnership meeting, as a virtual meeting, on March 29, 2022. The agenda for the meeting is as follows: • Welcoming and Opening Remarks (9:00 – 9:10 am ET) — Daniel Sullivan and Gary Jones, Directors, TC1600, USPTO • Claim Construction and Doctrine of Equivalents — A review for the Patent Office (9:10 – 10:30 am) — Henry C. Su, Bradley Arant Boult Cummings LLP Break (10:30 – 10:40 am) • Statutory provisions governing patent infringement — A practical analysis (10:40 – 11:40 am) — Christopher J….
